Formally known as Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate , PRL-8-53 is a synthetic compound derived from benzoic acid. It was first synthesized in the 1970s by Dr. Nikolaus Hansl at Creighton University. It was classified as a "hypermnesic" drug—a substance hypothesized to enhance memory beyond baseline levels. How It Works: The Mechanism
It may interact with dopamine pathways, which are linked to focus and motivation. prl 8 53 buy
While the exact mechanism of action is still being explored, research suggests PRL-8-53 may interact with several key neurotransmitter pathways: It was classified as a "hypermnesic" drug—a substance
Subjects who took a small dose saw an increase in their ability to remember lists of words when tested 24 hours later. The findings included:
Because human research is extremely limited, most information regarding usage is derived from the original 1970s studies or anecdotal reports: The primary human study utilized a 5 mg dose.
Participants over 30 years old or those with lower initial scores showed the most significant improvements in recall during the study.
The most notable evidence for PRL-8-53 comes from a 1978 human trial. The findings included: